Senate panel advances major drug-pricing bill; GOP defections over 'price controls' raise doubts

The Senate Finance Committee advanced legislation Thursday that caps seniors' out-of-pocket costs and forces drugmakers to reimburse the Medicare prescription-drug program when they increase prices faster than inflation.

It cleared the committee on a bipartisan, 19-9 vote that split Republicans, with some fearing it established "price controls" that abandon free-market ...